Antipsychotics for children and young adults: a comparative effectiveness review.
about
Obesity in children with autism spectrum disorderThe risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysisThe effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in childrenUse of antipsychotic medications in pediatric populations: what do the data say?Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations.Analysis of pediatric clinical drug trials for neuropsychiatric conditionsMetabolic consequences of second-generation antipsychotics in youth: appropriate monitoring and clinical management.A retrospective study of antipsychotic drug switching in a pediatric population.A Qualitative Study of Antipsychotic Medication Experiences of YouthQuality concerns in antipsychotic prescribing for youth: a review of treatment guidelines.Quetiapine safety in older adults: a systematic literature review.Antipsychotic treatment patterns and aggressive behavior among adolescents in residential facilities.Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.National trends in off-label use of atypical antipsychotics in children and adolescents in the United States.Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.Differential long-term effects of haloperidol and risperidone on the acquisition and performance of tasks of spatial working and short-term memory and sustained attention in rats.System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescentsA surveillance system to assess the need for updating systematic reviews.Early Antipsychotic Treatment in Juvenile Rats Elicits Long-Term Alterations to the Dopamine Neurotransmitter System.Youth, caregiver, and prescriber experiences of antipsychotic-related weight gain.SENTIA: a systematic online monitoring registry for children and adolescents treated with antipsychotics.The use of antipsychotics in preschoolers: a veto or a sensible last option?Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Atypical antipsychotics for disruptive behaviour disorders in children and youths.Child Psychiatric Emergencies: Updates on Trends, Clinical Care, and Practice Challenges.Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.Neural changes induced by antipsychotic administration in adolescence: A review of studies in laboratory rodents.Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Prevalence of Antidiabetic and Antilipidemic Medications in Children and Adolescents Treated With Atypical Antipsychotics in a Virginia Medicaid Population.Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats.Clinical picture and treatment implication in a child with Capgras syndrome: a case report.Factors associated with six-year weight change in young and middle-aged adults in the Young Finns Study.Antipsychotic Polypharmacy among Children and Young Adults in Office-Based or Hospital Outpatient Department Settings.Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors.
P2860
Q26860363-C66B0DFE-F60A-496B-B0DE-A580C97E0698Q26996493-985DE909-C382-4045-B3D6-28961BA57BA0Q28537908-10DF2CEC-A6E9-482A-AD84-28D940F7C3B9Q30698390-48EC191B-4560-4172-9ED8-6C76470EE3E3Q30773209-C1EA35C2-6E3B-4FE7-99FB-A07AB1420D68Q33617259-ECF8D9F9-13E8-4E20-9CE6-A051DC0A8286Q33819758-52BEF349-9B9F-43EB-B246-9F04137085F2Q34292768-EE58833C-7CD0-419B-919D-A5D1F66FD9E2Q35011070-16204EDB-393E-4DFC-95A0-B51EBAAD94B0Q35170541-43AC5C0E-7C14-4E11-84C4-B473720E2499Q35801186-88EFA86F-2886-4E60-A307-E87AC6394542Q35905294-3716B452-7A69-4CFA-A32A-4F3C9EBA0ECBQ36799433-3DB56836-4461-4E00-ACAA-45DE6FCF7239Q36925903-3D185C75-6734-4856-AB03-40B9DA7B15C4Q37003651-E127E347-22C0-4BD0-8FB4-92AEFF2EE11EQ37061277-DD396212-B9CF-4D88-BADF-06E56991E7A7Q37331835-1C2A5DAA-8B2F-4413-A9FA-3D920FF0247FQ37391342-77E1E7F1-6C87-4602-A441-01F69A6020C1Q37418168-EDEFC820-179A-45C5-8B79-855FF8EABF26Q37465755-A0C725C5-42FC-4860-9ABB-016CDBF9B4CFQ37515292-503B5C86-139E-408D-8C52-16028D00ACF6Q37724890-91EE73B4-B327-4910-8DC3-9467D647CD90Q38180865-B176B6A2-BE38-486F-A0B0-99AAD1FFDD3BQ38473914-719101D4-F5B9-47F7-A0E2-46FFE864FE57Q38632745-2E5646F7-B6A0-4CF5-8864-1B1379A4DB47Q38757127-C4B03D68-2A6B-463C-8FCB-636B95D64EDFQ38821689-C806A3D4-A4DD-40AF-8957-660A5ACFF793Q38842111-58CFB57A-DD90-4FC5-9335-7321E1DEFAB0Q39422983-9F5E7A32-51AD-41FE-BF00-6CAC869B1CC4Q40400512-58E113C9-14FF-4DA5-A5B9-DB89383D52C0Q40836016-B9B75440-F1E1-4B50-A043-87E0428AFBE2Q41118486-806105E7-0C4B-464D-9201-8CB3931F4029Q42095348-39BBB4E9-B89F-4C38-A505-5C30F1866100Q43972217-946E4631-878D-405D-B35A-145300B537BBQ47571460-E87A1055-94E8-4A04-84E4-98653D815FB1Q55431729-97B95B24-2369-4929-B4C3-EBE43D2183B1
P2860
Antipsychotics for children and young adults: a comparative effectiveness review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antipsychotics for children and young adults: a comparative effectiveness review.
@en
Antipsychotics for children and young adults: a comparative effectiveness review.
@nl
type
label
Antipsychotics for children and young adults: a comparative effectiveness review.
@en
Antipsychotics for children and young adults: a comparative effectiveness review.
@nl
prefLabel
Antipsychotics for children and young adults: a comparative effectiveness review.
@en
Antipsychotics for children and young adults: a comparative effectiveness review.
@nl
P2093
P356
P1433
P1476
Antipsychotics for children and young adults: a comparative effectiveness review.
@en
P2093
Amanda S Newton
Amy Beaith
Ben Vandermeer
Donna M Dryden
Janine R Schouten
Jennifer C Seida
Khrista Boylan
Normand Carrey
Shima S Mousavi
P304
P356
10.1542/PEDS.2011-2158
P407
P577
2012-02-20T00:00:00Z